|
Apr 16
|
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
|
|
Apr 15
|
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers
|
|
Apr 15
|
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
|
|
Apr 15
|
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
|
|
Apr 13
|
3 Magnificent Stocks That Could Double or More by 2030
|
|
Apr 13
|
Could This Stock Be the Next Biotech Buyout?
|
|
Apr 12
|
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex
|
|
Apr 12
|
Health Care Roundup: Market Talk
|
|
Apr 11
|
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
|
|
Apr 11
|
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
|
|
Apr 11
|
Vertex Pharmaceuticals Seeks a Second Act With Alpine Immune Deal. What Wall Street Says.
|
|
Apr 11
|
Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised
|
|
Apr 11
|
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
|
|
Apr 11
|
These Stocks Are Moving the Most Today
|
|
Apr 11
|
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer
|
|
Apr 11
|
Vertex Pharmaceuticals: Buy, Sell, or Hold?
|
|
Apr 11
|
US STOCKS-Futures slip as rate-cut hopes ebb
|
|
Apr 10
|
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
|
|
Apr 10
|
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
|
|
Apr 10
|
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion
|